全球醫療保健合約研究組織 (CRO) 市場規模、佔有率、趨勢和成長分析報告（2026-2034 年）

預計醫療保健 CRO（合約研究組織）市場將從 2025 年的 525.6 億美元成長到 2034 年的 1,013.6 億美元，2026 年至 2034 年的複合年成長率為 7.57%。

隨著製藥和生物技術公司擴大將研發活動外包，全球醫療保健CRO（合約研究組織）市場正在迅速擴張。 CRO提供廣泛的服務，包括臨床試驗、法規支援、資料管理和實驗室檢測。透過外包這些活動，公司可以降低營運成本、縮短藥物研發週期，並專注於其核心業務。

推動該市場發展的主要因素之一是臨床試驗和監管要求的日益複雜化。製藥公司正與合約研究組織 (CRO) 合作，以充分利用其專業知識、先進技術和全球研究網路。此外，藥物研發計畫的增加和對創新治療方法需求的成長也進一步推動了對合約研究服務的需求。

受製藥和生技產業持續擴張的推動，醫療保健CRO市場預計未來將保持強勁成長。分散式臨床試驗、數位資料收集和人工智慧分析等技術進步正在變革研究運作模式。亞太地區的新興市場憑藉其成本優勢和不斷提升的臨床研究能力，預計將在市場擴張中發揮重要作用。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

• 市場譜系展望
• 滲透率和成長前景分析
• 價值鏈分析
• 法律規範
  • 標準與合規性
  • 監管影響分析
• 市場動態
  • 市場促進因素
  • 市場限制因素
  • 市場機遇
  • 市場挑戰
• 波特五力分析
• PESTLE分析

第4章：全球醫療保健合約研究組織 (CRO) 市場：按類型分類

• 市場分析、洞察與預測
• 藥物發現（標靶檢驗、先導化合物鑑定、先導化合物最佳化）
• 臨床前
• 臨床（I期臨床試驗服務、II期臨床試驗服務、III期臨床試驗服務、IV期臨床試驗服務）

第5章：全球醫療保健合約研究組織 (CRO) 市場：按服務分類

• 市場分析、洞察與預測
• 計劃管理/臨床供應管理
• 資料管理
• 法規和醫療事務
• 醫用照明
• 臨床監測
• 品管/保證
• 生物統計學
• 臨床實驗主要研究者的補償
• 檢查室
• 受試者招募和臨床實驗中心
• 科技
• 其他

第6章：全球醫療保健合約研究組織 (CRO) 市場：按治療領域分類

• 市場分析、洞察與預測
• 腫瘤學
• 中樞神經系統疾病
• 感染疾病
• 免疫系統疾病
• 心血管疾病
• 呼吸系統疾病
• 糖尿病
• 眼科
• 疼痛管理
• 其他

第7章 全球醫療保健合約研究組織 (CRO) 市場：按分子分類

• 市場分析、洞察與預測
• 製藥

第8章：全球醫療保健合約研究組織 (CRO) 市場：按地區分類

• 區域分析
• 北美市場分析、洞察與預測
  • 美國
  • 加拿大
  • 墨西哥
• 歐洲市場分析、洞察與預測
  • 英國
  • 法國
  • 德國
  • 義大利
  • 俄羅斯
  • 其他歐洲國家
• 亞太市場分析、洞察與預測
  • 印度
  • 日本
  • 韓國
  • 澳洲
  • 東南亞
  • 其他亞太國家
• 拉丁美洲市場分析、洞察與預測
  • 巴西
  • 阿根廷
  • 秘魯
  • 智利
  • 其他拉丁美洲國家
• 中東和非洲市場分析、洞察與預測
  • 沙烏地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中東和非洲國家

第9章 競爭情勢

• 最新趨勢
• 公司分類
• 供應鏈和銷售管道合作夥伴（根據現有資訊）
• 市場佔有率和市場定位分析（基於現有資訊）
• 供應商情況（基於現有資訊）
• 策略規劃

第10章：公司簡介

• 主要公司的市佔率分析
• 公司簡介
  • LabCorp
  • Iqvia Inc
  • Thermo Fisher Scientific
  • Icon Plc
  • Syneos Health
  • Charles River Laboratories
  • Parexel International Corporation
  • WuXi AppTec
  • Medpace
  • Sgs Sa
  • Worldwide Clinical Trials
  • Pharmaron GmbH
  • CTI Clinical Trial & Consulting
  • Ergomed
  • GVK Biosciences Private Limited（Aragen）

The Healthcare Contract Research Organization Market size is expected to reach USD 101.36 Billion in 2034 from USD 52.56 Billion (2025) growing at a CAGR of 7.57% during 2026-2034.

The global healthcare contract research organization (CRO) market is expanding rapidly as pharmaceutical and biotechnology companies increasingly outsource research and development activities. CROs provide a wide range of services including clinical trials, regulatory support, data management, and laboratory testing. Outsourcing these activities helps companies reduce operational costs, accelerate drug development timelines, and focus on core competencies.

One of the primary drivers of this market is the growing complexity of clinical trials and regulatory requirements. Pharmaceutical companies are partnering with CROs to access specialized expertise, advanced technologies, and global research networks. Additionally, the increasing number of drug development programs and the rising demand for innovative therapies are further driving the need for contract research services.

Looking forward, the healthcare CRO market is expected to witness strong growth due to the continuous expansion of the pharmaceutical and biotechnology sectors. Technological advancements such as decentralized clinical trials, digital data collection, and artificial intelligence-driven analytics are transforming research operations. Emerging markets in Asia-Pacific are expected to play a key role in market expansion due to cost advantages and growing clinical research capabilities.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Type

• Drug Discovery (Target Validation, Lead Identification, Lead Optimization)
• Pre-Clinical
• Clinical (Phase I Trial Services, Phase II Trial Services, Phase III Trial Services, Phase IV Trial Services)

By Service

• Project Management/Clinical Supply Management
• Data Management
• Regulatory/Medical Affairs
• Medical Writing
• Clinical Monitoring
• Quality Management/ Assurance
• Bio-statistics
• Investigator Payments
• Laboratory
• Patient And Site Recruitment
• Technology
• Others

By Therapeutic Area

• Oncology
• CNS Disorders
• Infectious Diseases
• Immunological Disorders
• Cardiovascular Diseases
• Respiratory Diseases
• Diabetes
• Ophthalmology
• Pain Management
• Others

By Molecule

• Pharmaceutical

COMPANIES PROFILED

• LabCorp, Iqvia Inc, Thermo Fisher Scientific, Icon Plc, Syneos Health, Charles River Laboratories, Parexel International Corporation, WuXi AppTec, Medpace, Sgs Sa, Worldwide Clinical Trials, Pharmaron GmbH, CTI Clinical Trial Consulting, Ergomed, GVK Biosciences Private Limited Aragen
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET: BY TYPE 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Type
• 4.2. Drug Discovery (Target Validation, Lead Identification, Lead Optimization) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Pre-Clinical Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Clinical (Phase I Trial Services, Phase II Trial Services, Phase III Trial Services, Phase IV Trial Services) Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET: BY SERVICE 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Service
• 5.2. Project Management/Clinical Supply Management Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Data Management Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Regulatory/Medical Affairs Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Medical Writing Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.6. Clinical Monitoring Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.7. Quality Management/ Assurance Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.8. Bio-statistics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.9. Investigator Payments Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.10. Laboratory Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.11. Patient And Site Recruitment Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.12. Technology Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.13. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET: BY THERAPEUTIC AREA 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Therapeutic Area
• 6.2. Oncology Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. CNS Disorders Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Infectious Diseases Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.5. Immunological Disorders Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.6. Cardiovascular Diseases Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.7. Respiratory Diseases Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.8. Diabetes Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.9. Ophthalmology Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.10. Pain Management Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.11. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET: BY MOLECULE 2022-2034 (USD MN)

• 7.1. Market Analysis, Insights and Forecast Molecule
• 7.2. Pharmaceutical Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET: BY REGION 2022-2034 (USD MN)

• 8.1. Regional Outlook
• 8.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.2.1 By Type
  • 8.2.2 By Service
  • 8.2.3 By Therapeutic Area
  • 8.2.4 By Molecule
  • 8.2.5 United States
  • 8.2.6 Canada
  • 8.2.7 Mexico
• 8.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.3.1 By Type
  • 8.3.2 By Service
  • 8.3.3 By Therapeutic Area
  • 8.3.4 By Molecule
  • 8.3.5 United Kingdom
  • 8.3.6 France
  • 8.3.7 Germany
  • 8.3.8 Italy
  • 8.3.9 Russia
  • 8.3.10 Rest Of Europe
• 8.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.4.1 By Type
  • 8.4.2 By Service
  • 8.4.3 By Therapeutic Area
  • 8.4.4 By Molecule
  • 8.4.5 India
  • 8.4.6 Japan
  • 8.4.7 South Korea
  • 8.4.8 Australia
  • 8.4.9 South East Asia
  • 8.4.10 Rest Of Asia Pacific
• 8.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.5.1 By Type
  • 8.5.2 By Service
  • 8.5.3 By Therapeutic Area
  • 8.5.4 By Molecule
  • 8.5.5 Brazil
  • 8.5.6 Argentina
  • 8.5.7 Peru
  • 8.5.8 Chile
  • 8.5.9 Rest of Latin America
• 8.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.6.1 By Type
  • 8.6.2 By Service
  • 8.6.3 By Therapeutic Area
  • 8.6.4 By Molecule
  • 8.6.5 Saudi Arabia
  • 8.6.6 UAE
  • 8.6.7 Israel
  • 8.6.8 South Africa
  • 8.6.9 Rest of the Middle East And Africa

Chapter 9. COMPETITIVE LANDSCAPE

• 9.1. Recent Developments
• 9.2. Company Categorization
• 9.3. Supply Chain & Channel Partners (based on availability)
• 9.4. Market Share & Positioning Analysis (based on availability)
• 9.5. Vendor Landscape (based on availability)
• 9.6. Strategy Mapping

Chapter 10. COMPANY PROFILES OF GLOBAL HEALTHCARE CONTRACT RESEARCH ORGANIZATION INDUSTRY

• 10.1. Top Companies Market Share Analysis
• 10.2. Company Profiles
  • 10.2.1 LabCorp
  • 10.2.2 Iqvia Inc
  • 10.2.3 Thermo Fisher Scientific
  • 10.2.4 Icon Plc
  • 10.2.5 Syneos Health
  • 10.2.6 Charles River Laboratories
  • 10.2.7 Parexel International Corporation
  • 10.2.8 WuXi AppTec
  • 10.2.9 Medpace
  • 10.2.10 Sgs Sa
  • 10.2.11 Worldwide Clinical Trials
  • 10.2.12 Pharmaron GmbH
  • 10.2.13 CTI Clinical Trial & Consulting
  • 10.2.14 Ergomed
  • 10.2.15 GVK Biosciences Private Limited (Aragen)